Acute hepatitis C

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Hepatology

• Publication date

  2001-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/jhep.2001.22112PMID 11172332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure, diversity, and evolution of the T-cell receptor VB gene repertoire in primates

  2004cited by this paper
• The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

  2000cited by this paper
• Immunoglobulin G and M Hepatitis C Virus Core Antibody (JCC.2) Response in Chimpanzees Infected Experimentally with Hepatitis C Virus

  2000cited by this paper
• Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

  2000cited by this paper
• CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

  2000cited by this paper
• Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.

  2000cited by this paper
• The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States

  2000cited by this paper
• Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

  2000cited by this paper
• The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

  1999cited by this paper
• Role of the specific T‐cell response for clearance and control of hepatitis C virus

  1999cited by this paper
• Viral clearance without destruction of infected cells during acute HBV infection.

  1999cited by this paper
• Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.

  1999cited by this paper
• Antiapoptotic and Oncogenic Potentials of Hepatitis C Virus Are Linked to Interferon Resistance by Viral Repression of the PKR Protein Kinase

  1999cited by this paper
• Prevalence of hepatitis C virus infection in the United States.

  1999cited by this paper
• Epidemiology of hepatitis C in the United States.

  1999cited by this paper
• Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.

  1999cited by this paper
• Hepatitis C: the clinical spectrum of the disease.

  1999cited by this paper
• Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: Impact of epitope variation and relationship to detection of HCV RNA in blood

  1999cited by this paper
• Treatment of acute hepatitis C virus infection.

  1999cited by this paper
• Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.

  1999cited by this paper
• Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection

  1999cited by this paper
• Analysis of a successful immune response against hepatitis C virus.

  1999cited by this paper
• Analysis of Hepatitis C Virus-Inoculated Chimpanzees Reveals Unexpected Clinical Profiles

  1998cited by this paper
• Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis

  1998cited by this paper
• Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients

  1998cited by this paper
• A major histocompatibility complex class I allele shared by two species of chimpanzee

  1998cited by this paper
• [The prevalence of hepatitis C virus infection].

  1998cited by this paper
• Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial.

  1998cited by this paper
• Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up

  1997cited by this paper
• Natural recovery from acute hepatitis C virus infection by agammaglobulinemic twin children.

  1997cited by this paper
• Interferon therapy for acute hepatitis C viral infection--a review by meta-analysis.

  1997cited by this paper
• Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients.

  1997cited by this paper
• Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus

  1997cited by this paper
• Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.

  1997cited by this paper
• Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons.

  1997cited by this paper
• Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C

  1997cited by this paper
• Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope

  1997cited by this paper
• Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team.

  1997cited by this paper
• Detection of type 2‐like T‐helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity

  1997cited by this paper
• Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor

  1997cited by this paper
• Hepatitis C: The clinical spectrum of disease

  1997cited by this paper
• Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

  1997cited by this paper
• High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.

  1996cited by this paper
• Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

  1996cited by this paper
• Effect of immune globulin on the prevention of experimental hepatitis C virus infection.

  1996cited by this paper
• Absence of anti‐envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977

  1996cited by this paper
• Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994

  1996cited by this paper
• Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.

  1995cited by this paper
• Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.

  1995cited by this paper
• Persistent hepatitis C viremia after acute self‐limiting posttransfusion hepatitis C

  1995cited by this paper
• Immunoglobulin M antibody to hepatitis C virus core antigen: Correlations with viral replication, histological activity, and liver disease outcome

  1995cited by this paper
• Evolution of Major Histocompatibility Complex Polymorphisms and T‐Cell Receptor Diversity in Primates

  1995cited by this paper
• Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

  1994cited by this paper
• A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C

  1994cited by this paper
• Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.

  1994cited by this paper
• Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group.

  1994cited by this paper
• Vaccination of chimpanzees against infection by the hepatitis C virus.

  1994cited by this paper
• Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

  1994cited by this paper
• Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient.

  1994cited by this paper
• [Interferon therapy for acute hepatitis C; changes in serum markers associated with HCV and clinical effects].

  1994cited by this paper
• The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha

  1994cited by this paper
• A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C.

  1994cited by this paper
• Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis.

  1993cited by this paper
• [A report on therapy of interferon-A2b in patients with acute hepatitis C].

  1993cited by this paper
• [A report on therapy of interferon-A2b in patients with acute hepatitis C].

  1993cited by this paper
• Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.

  1993cited by this paper
• Interferon‐α in acute posttransfusion hepatitis C:. A randomized, controlled trial

  1992cited by this paper
• The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

  1992cited by this paper
• The natural history of community-acquired hepatitis C in the United States.

  1992cited by this paper
• Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.

  1992cited by this paper
• Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial.

  1992cited by this paper
• Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

  1992cited by this paper
• Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.

  1992cited by this paper
• Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.

  1991cited by this paper
• A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

  1991cited by this paper
• Resolution of acute hepatitis C after therapy with natural beta interferon.

  1991cited by this paper
• IgM antibody to hepatitis C virus in acute and chronic hepatitis C

  1991cited by this paper
• Comparison of Class I MHC Alleles in Humans and Apes

  1990cited by this paper
• Third national health and nutrition examination survey

  1985cited by this paper
• On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.

  1983cited by this paper
• NATIONAL CENTER FOR HEALTH STATISTICS

  1980cited by this paper

• Prevalence of hepatitis C virus infection in Qatar’s resident population based on a national screening campaign

  2025cites this paper
• Management Strategies of Fatal Liver Infection Due to Hepatitis C Virus (HCV)

  2025cites this paper
• Recently acquired hepatitis C virus infection in people with HIV - what have we learned?

  2025cites this paper
• Prevalence of hepatitis B and C viruses among migrant workers in Qatar

  2024cites this paper
• Treatment results of our patients with acute viral hepatitis C

  2023cites this paper
• Susceptibilidad genética y aclaramiento viral de la infección por Virus de la Hepatitis C

  2023cites this paper
• Prevalence and predictors of hepatitis C infection among antenatal attendees in a tertiary hospital in Southern Nigeria

  2023cites this paper
• Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America

  2022cites this paper
• A CURE FOR RECENTLY ACQUIRED HEPATITIS C

  2022cites this paper
• Facteurs prédictifs de l’encéphalopathie hépatique au cours de l’atteinte hépatique aiguë sévère

  2022cites this paper
• Implementation of a controlled human infection model for evaluation of HCV vaccine candidates

  2022cites this paper
• Severe Acute Hepatitis Outbreaks Associated with a Novel Hepacivirus in Rhizomys pruinosus in Hainan, China

  2022cites this paper
• Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection

  2021cites this paper
• HIV and Hepatitis C in Corrections: A Public Health Opportunity

  2021cites this paper
• Epidemiological and Clinical Factors Associated with Spontaneous Clearance of Hepatitis C Virus

  2021cites this paper
• Non-Surgical Periodontal Therapy Could Improve the Periodontal Inflammatory Status in Patients with Periodontitis and Chronic Hepatitis C

  2021cites this paper
• Association of blood groups with hepatitis C viremia

  2021cites this paper
• The Global Burden of Viral Hepatitis 1990-2013

  2021cites this paper
• Elbasvir and grazoprevir for the treatment of hepatitis C

  2021cites this paper
• Absence of interferon-lambda 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection

  2021cites this paper
• Viral hepatitis: Milestones, unresolved issues, and future goals

  2021cites this paper
• Natural History of Hepatitis C Infection

  2021cites this paper
• Sexually Transmitted Infections Treatment Guidelines, 2021

  2021cites this paper
• Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study

  2021cites this paper
• Acute Viral Hepatitis

  2020cites this paper
• Evaluation of Risk Factors for Hepatitis C Virus Infection Among Philadelphia's Shelter-Bound, Homeless Population: Data from a Student-Run Hepatitis C Virus Screening Initiative

  2020cites this paper
• Akute und chronische Hepatitis

  2020cites this paper
• Hepatitis C Virus Infection in Pregnancy

  2020cites this paper
• Viral Hepatitis

  2020cites this paper
• Hepatitis C : prevalence, risk factors and implications for screening

  2020cites this paper
• EASL recommendations on treatment of hepatitis C - Final update of the series.

  2020cites this paper
• Antibody Responses in Hepatitis C Infection.

  2020cites this paper
• Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases consensus panel European Treatment Network for HIV, Hepatitis and Global Infectious Diseases (NEAT-ID) Consensus Panel

  2020cites this paper
• A Histological Study on the Possible Adverse Effect of Sofosbuvir on Lungs of Adult Male Albino Rats

  2020cites this paper
• Recently acquired and early chronic hepatitis C in men having sex with men (MSM): Recommendations from the NEAT-ID consensus panel.

  2020cites this paper
• Hepatitis C Competency and Outreach of Occupational Health Nurses

  2019cites this paper
• Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?

  2019cites this paper
• Acute Hepatitis

  2019cites this paper
• Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam

  2019cites this paper
• The phylogenetic approach for viral infectious disease evolution and epidemiology: An updating review

  2019cites this paper
• Relationships between air pollutants and mortality in Portugal – an environmental health assessment

  2019cites this paper
• Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study

  2019cites this paper
• Laboratory Diagnosis and Monitoring of Viral Hepatitis.

  2019cites this paper
• Determination of HCV Genotypes and Viral Loads in Chronic Hepatic Sudanese infected Patients

  2019cites this paper
• Viral Hepatitis: Acute Hepatitis

  2019cites this paper
• Acute Hepatitis C

  2019cites this paper
• Safety and efficacy of sofosbuvir‐based treatment of acute hepatitis C in end‐stage renal disease patients undergoing haemodialysis

  2018cites this paper
• 6 – Viral Hepatitis

  2018cites this paper
• Protease inhibitor therapy for hepatitis C virus-infection

  2018cites this paper
• Management of acute HCV infection in the era of direct-acting antiviral therapy

  2018cites this paper
• [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

  2018cites this paper
• Hepatitis C and human immunodeficiency virus coinfection in the era of direct‐acting antiviral agents: No longer a difficult‐to‐treat population

  2018cites this paper
• Characterizing the temporal evolution of the hepatitis C virus epidemic in Pakistan

  2018cites this paper
• Promjene u sestrinskoj skrbi za pacijente s kroničnim hepatitisom c nakon uvođenja direktno djelujuće antivirusne terapije

  2018cites this paper
• Exposure to hepatitis C virus early in life : Epidemiological and Immunological aspects

  2018cites this paper
• Liver and Bile Duct Infections

  2017cites this paper
• VALIDATED CAPILLARY ZONE ELECTROPHORESIS APPROACH FOR SIMULTANEOUS SEPARATION AND DETERMINATION OF HEPATITIS C SOFOSBUVIR AND LEDIPASVIR IN TABLET DOSAGE FORM

  2017cites this paper
• Infection and propagation of hepatitis C virus in human CD4⁺ and CD8⁺ T lymphocytes in vitro

  2017cites this paper
• Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China

  2017cites this paper
• Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.

  2017cites this paper
• Hepatitis C virus infection in children and adolescents

  2017cites this paper
• Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention

  2017cites this paper
• Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals

  2017cites this paper
• HBV/HCV co‐infection is associated with a high level of HCV spontaneous clearance among drug users and blood donors in China

  2017cites this paper
• Mixed genotype Hepatitis C virus infections: incidence in Scotland and methods for detection

  2017cites this paper
• Akutes Leberversagen als seltene Manifestation einer häufigen Erkrankung

  2017influential citation
• Hepatitis C virus infection

  2017influential citation
• A novel method for viral protein tracking in host cells

  2017cites this paper
• Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing

  2017cites this paper
• Sexual behaviour of HIV-diagnosed men who have sex with men in England in the era of effective antiretroviral therapy: results from the ASTRA study

  2017cites this paper
• Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients

  2017cites this paper
• Clinical epidemiology of acute hepatitis C in South America

  2017influential citation
• The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia

  2016cites this paper
• The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.

  2016cites this paper
• Detección y seguimiento de los efectos adversos neuropsiquiátricos en pacientes con hepatitis C crónica en tratamiento con peginterferón alfa-2 y ribavirina

  2016cites this paper
• Liver Failure due to Acute Viral Hepatitis (A-E)

  2016cites this paper
• Evolution of the Humoral Response during HCV Infection: Theories on the Origin of Broadly Neutralizing Antibodies and Implications for Vaccine Design.

  2016cites this paper
• Hepatitis C Virus Core Gene Polymorphism in Cases of Hepatocellular Carcinoma

  2016cites this paper
• GENERALIZED MATHEMATICAL MODEL OF CHRONIC HEPATITIS C INFECTION

  2016cites this paper
• Analyse génomique de la coinfection par le virus VIH et VHC

  2016cites this paper
• Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals

  2016cites this paper
• The Dynamics of Incidence of Chronic Hepatitis B and C in the Population of Almaty city for 2001-2014

  2016cites this paper
• Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child.

  2016cites this paper
• Hepatitis C Virus Infection among Pregnant Women in Ibadan, Nigeria: Prevalence, Correlates and Co-infection with HIV

  2016influential citation
• Frequency of Hepatitis B and C Co-Infection in Chronic Liver Disease Patients in Calabar, Cross River State, Nigeria.

  2016cites this paper
• Nonarteritic anterior ischemic optic neuropathy associated with interferon and ribavirin in a patient with hepatitis C

  2016cites this paper
• Antiviral Host Defence Peptides

  2016cites this paper
• Micro RNAs mir‐106a, mir‐122 and mir‐197 are increased in severe acute viral hepatitis with coagulopathy

  2016cites this paper
• Hepatic Failure

  2016cites this paper
• The Natural History of Hepatit is C Viral Infection: Clinical Evaluation and Monitoring

  2016cites this paper
• Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection

  2016cites this paper
• Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release

  2015cites this paper
• Enhancing the detection and management of acute hepatitis C virus infection.

  2015cites this paper
• CYTOKINES LEVELS AND THEIR RELATIONSHIP WITH CLINICAL CORRELATES IN HUMAN IMMUNODEFICIENCY VIRUS/HEPATITIS C CO- INFECTED DRUG USERS FROM MOMBASA COUNTY, KENYA

  2015influential citation
• HEPATITIS C VIRUS INFECTION

  2015cites this paper
• Mutual Predators: A Descriptive Cross-Sectional Study to Identify Prevalence of Hepatitis C Virus and Human Immunodeficiency Virus Type-1 Mono and Co-Infection

  2015cites this paper
• Biomarkers in HCV Infection.

  2015cites this paper
• Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification

  2015cites this paper
• Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.

  2015cites this paper
• Development of Biomolecular Tools for Studying Host-Virus Interactions of the Hepatitis C Virus

  2015cites this paper